BORIANI, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 19.236
EU - Europa 16.344
AS - Asia 7.817
AF - Africa 835
SA - Sud America 30
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 10
Totale 44.294
Nazione #
US - Stati Uniti d'America 19.201
GB - Regno Unito 5.243
CN - Cina 2.895
IT - Italia 2.731
DE - Germania 2.328
VN - Vietnam 1.971
UA - Ucraina 1.925
SG - Singapore 1.793
SE - Svezia 1.189
IN - India 936
FR - Francia 774
RU - Federazione Russa 683
IE - Irlanda 574
EE - Estonia 445
ZA - Sudafrica 330
CI - Costa d'Avorio 173
SC - Seychelles 161
TG - Togo 118
FI - Finlandia 79
CH - Svizzera 73
BG - Bulgaria 69
JO - Giordania 50
BE - Belgio 46
GR - Grecia 45
NG - Nigeria 45
NL - Olanda 42
IR - Iran 38
CA - Canada 32
JP - Giappone 32
LB - Libano 26
PL - Polonia 16
AU - Australia 15
UZ - Uzbekistan 15
RO - Romania 14
CL - Cile 13
CZ - Repubblica Ceca 13
HR - Croazia 13
BR - Brasile 12
KR - Corea 12
AT - Austria 10
TR - Turchia 10
ES - Italia 8
HK - Hong Kong 8
EU - Europa 7
NZ - Nuova Zelanda 7
KZ - Kazakistan 5
BD - Bangladesh 4
DK - Danimarca 4
HU - Ungheria 4
ID - Indonesia 4
PT - Portogallo 4
SA - Arabia Saudita 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EG - Egitto 3
NO - Norvegia 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
LK - Sri Lanka 2
MD - Moldavia 2
MU - Mauritius 2
MX - Messico 2
MY - Malesia 2
PE - Perù 2
SN - Senegal 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
HT - Haiti 1
IQ - Iraq 1
KW - Kuwait 1
LU - Lussemburgo 1
MA - Marocco 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
VE - Venezuela 1
Totale 44.294
Città #
Southend 4.731
Fairfield 2.538
Singapore 1.625
Ashburn 1.604
Jacksonville 1.378
Wilmington 1.281
Woodbridge 1.166
Seattle 1.133
Princeton 1.112
Chandler 1.098
Houston 1.067
Cambridge 869
Dong Ket 788
Ann Arbor 659
Boardman 589
Dublin 573
Westminster 506
Padova 503
Nanjing 482
Santa Clara 438
Berlin 308
Medford 255
Saint Petersburg 254
Jinan 235
Shenyang 223
Mülheim 215
Milan 199
San Diego 188
Abidjan 173
Bologna 163
Mahé 160
Changsha 159
Hebei 157
Nanchang 147
Beijing 129
Bremen 122
Lomé 118
Rome 104
Jiaxing 102
Turin 102
Tianjin 99
New York 91
Olalla 88
Des Moines 85
Verona 82
Helsinki 78
Norwalk 73
Guangzhou 71
Zhengzhou 68
Hangzhou 67
Dearborn 66
Ningbo 66
Shanghai 64
Sofia 63
Falls Church 58
Haikou 58
Amman 50
Mountain View 48
Brussels 44
San Venanzo 44
Abeokuta 42
Lanzhou 42
Taizhou 42
Bern 40
Bühl 38
Kunming 38
Taiyuan 36
Bari 33
Florence 33
Fuzhou 33
Los Angeles 33
London 31
Tokyo 27
Redmond 26
Redwood City 25
Chengdu 19
Frankfurt Am Main 19
Shenzhen 19
Ardabil 18
Chicago 18
Monmouth Junction 18
Paris 18
Toronto 18
Harbin 17
Leawood 17
Genzano Di Roma 16
Pune 16
Qingdao 15
Hefei 14
Messina 14
Monterotondo 14
Naples 14
Plauen 14
Lausanne 13
Phoenix 12
Andover 11
Costa Mesa 11
Groningen 11
Wuhan 11
Den Haag 10
Totale 29.912
Nome #
Incremento dei valori di troponina T dopo impianto di pacemaker con elettrodi a fissaggio attivo e passivo. 787
Psychological correlates, allostatic overload and clinical course in patients with implantable cardioverter defibrillator (ICD) 289
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 221
Incidenza e fattori predittivi di fibrillazione atriale post operatoria nei riceventi di trapianto renale 193
Fattori predittivi di rimodellamento cardiaco inverso del ventricolo sinistro in pazienti candidati a terapia di resincronizzazione cardiaca: il ruolo dell’eziologia. 189
Aritimie cardiache, morte cardiaca improvvisa, sincope 183
Actual pacemaker longevity: the benefit of stimulation by automatic capture verification. 181
Changes in exercise capacity induced by heart transplantation: prognostic and therapeutic implications. 177
La tachicardiomiopatia: una revisione della letteratura 174
Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy. 168
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel. 159
AF burden is important - Fact or fiction? 156
Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation 156
A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance. 154
Biventricular ICDs and rhythm discrimination by analysis of QRS morphology: are there QRS changes associated with left ventricular reverse remodeling? Poster European Congress of Cardiology 2007 151
Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy 151
Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. 151
Automatic verification of ventricular stimulation: fusion management algorithm 147
Battery drain in daily practice and medium-term projections on longevity of cardioverterdefibrillators: An analysis from a remote monitoring database 147
Atrial fibrillation ablation: beyond electro-mechanical matters 144
Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation 143
Assessment of regional left ventricular function by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 142
Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry 142
11C-mHED for PET / CT: principles of synthesis, methodology and first clinical applications 140
A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study. 140
Acute changes in electromechanical parameters during different pacing configurations using a quadripolar left ventricular lead 138
Electrocardiographic remodeling during cardiac resynchronization therapy 136
Automatic management of left ventricular stimulation: hints for technologic improvement. 134
Cardiac resynchronization therapy: a comparison among left ventricular bipolar, quadripolar and active fixation leads 134
A comparison among three different echocardiographic methods for Interventricular delay optimization. Poster European Congress of Cardiology 2008 133
A prospective randomized evaluation of VV delay optimization in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 131
Atrial fibrillation in heart failure patients undergoing resynchronization therapy: what decision making? Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques 131
Rate control in AFFIRM: considerations about the clinical implications. 130
P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion. 130
Atrial fibrillation and heart failure: does one epidemic feed he other? 130
Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation 130
A controlled study on the effect of verapamil on atrial tachycaarrhythmias in patients with brady-tachy syndrome implanted with a DDDR pacemaker. 130
A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial. 128
Automatic management of atrial and ventricular stimulation in a contemporary unselected population of pacemaker recipients: the ESSENTIAL Registry 128
'Real-World' antithrombotic treatment in atrial fibrillation: The eorp-af pilot survey 127
Pharmacological cardioversion of atrial fibrillation : current management and treatment options. 126
Biventricular Pacing: Electrocardiographic Versus Structural Remodeling 125
How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint. 125
Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction 125
Effects of cardiac resynchronization therapy on diastolic function: evaluation by radionuclide angiography. 125
A new algorithm for ventricular capture detection in ICDs, in Proceedings XI International Symposium Progress in Clinical Pacing 124
Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy. 124
Solution to a crushing dosage problem? 123
Incidence and Predictors of Postoperative Atrial Fibrillation in Kidney Transplant Recipients. 123
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization. 123
Evaluation of fusion beat detection with a new ventricular automatic capture algorithm in ICDs. 122
Cardiac resynchronization therapy : effects on left and right ventricular ejection fraction during exercise 122
Resolution of atrial thrombosis with heparin in a newborn with atrial flutter 122
Targeting the arrhythmogenic substrate in atrial fibrillation: focus on structural remodeling 122
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 122
Dilated-Hypokinetic evolution of hypertrophic cardiomyopathy 122
Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy 121
Heart failure after myocardial revascularization: Risk markers. 120
Confronto fra impedenziometria transtoracica ed ecocardiografia doppler nell'ottimizzazione della programmazione dell'intervallo ventricolo-ventricolare. 119
Cardiac resynchronization therapy: effects on left and right ventricular ejection fraction during exercise. 119
Algoritmi diagnostici nei defibrillatori mono e bicamerali: analisi delle capacità di discriminazione delle aritmie sopraventricolari e ventricolari. 119
Troponin I rise after pacemaker implantation at the time of "universal definition of myocardial infarction" 119
Automatic management of left ventricular pacing output: effectiveness of stimulation and device longevity. Proceedings XIII International symposium on Progress in Clinical Pacing 118
Clinical management of atrial fibrillation: need for a comprehensive patient-centered approach. 118
Implantable electrical devices for prevention of sudden cardiac death: data on implant rates from a 'real world' regional registry. 116
Cardioversione atriale interna: valutazione prospettica dei fattori determinanti il dolore indotto dallo shock. 115
Valutazione angiocardioscintigrafica dei pazienti sottoposti aterapia di resincronizzazione cardiaca; esperienza del centro di Bologna. 115
La cardioversione elettrica nella pratica clinica:quali predittori di efficacia della procedura e di recidiva di fibrillazione/flutter atriale a lungo termine? 115
Cardiac resynchronization by pacing: an electrical treatment of heart failure 115
A plateau waveform shape allows a much higher patient shock energy tolerance 114
Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. 114
Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation 114
Resincronizzazione cardiaca con pacing biventricolare o ventricolare sinistro: effetti a medio termine su funzione sistolica e sincronia ventricolare sinistra 113
Letter by Boriani et al regarding article, "Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study". 113
Decrease in patient radiation exposure by a tantalum filter during electrophysiological procedures. 113
Cardiac resynchronization therapy: is systole all that matters? 113
Biventricular pacing in heart failure: what relationship between electrocardiographic and structural remodeling? 113
Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: Time courses and prediction of response. 112
Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. 112
Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. 112
Automatic verification of ventricular stimulation: fusion management algorithm 112
QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus 111
Comparison of two strategies to reduce ventricular pacing in pacemaker patients 111
Left ventricular rotational mechanics in acute myocardial infarction and in chronic (ischemic and nonischemic) heart failure patients. 111
Cardiac resynchronization therapy and VV interval optimization: which relationship between QRS width and the results of echo-guided VV interval optimization? 110
'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: The EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry 110
Atrial fibrillation in patients with a dual defibrillator: characteristics of spontaneous and induced episodes and effect of ventricular tachyarrhythmia induction. 110
How to truly value implantable cardioverter-defibrillators technology: Up-front cost or daily cost? 110
Fibrillazione atriale e terapia di resincronizzazione cardiaca: quale strategia? 110
Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. 110
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs 110
Atrial fibrillation therapy in patients with a CRT defibrillator with wireless telemetry. 109
Expenditure and value for money: the challenge of implantable cardioverter defibrillators 109
Balancing the risk of hemorrhage vs thromboembolism in patients with atrial fibrillation: how to navigate between Scylla and Charybdis? 109
Treatment of atrial fibrillation with a dual defibrillator in heart failure patients (TRADE HF): protocol for a randomized clinical trial. 109
Role of severe functional mitral regurgitation in predicting electrical remodeling in idiopathic dilated cardiomyopathy. 109
Pacing with capture verification in candidates for resynchronisation therapy: a feasibility study. 108
Cardioverter defibrillators in primary prevention of sudden cardiac death: a cost or an investment? 108
Duration of P-wave is associated with atrial fibrillation hospitalizations in patients with atrial fibrillation and paced for bradycardia. 108
Evaluation of the atrial evoked response for capture detection with high-polarization leads. 108
Totale 13.694
Categoria #
all - tutte 105.585
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.585


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.756 0 0 0 0 1.031 1.169 1.362 1.538 1.414 789 367 1.086
2020/20216.935 1.552 485 174 397 97 325 62 402 394 392 335 2.320
2021/20227.490 672 377 511 628 774 554 146 603 236 254 1.164 1.571
2022/20236.922 851 887 354 956 380 378 212 349 1.139 335 655 426
2023/20241.655 136 286 114 122 176 276 120 88 82 108 57 90
2024/20254.285 241 1.806 622 643 973 0 0 0 0 0 0 0
Totale 44.979